Enantiospecific synthesis and cytotoxicity of 7-(4-methoxyphenyl)-6-phenyl-2,3,8,8a-tetrahydroindolizin-5(1H)-one enantiomers

F. Scott Kimball; Brandon J. Turunen; Keith C. Ellis; Richard H. Himes; Gunda I. Georg

doi:10.1016/j.bmc.2008.02.073

Enantiospecific synthesis and cytotoxicity of 7-(4-methoxyphenyl)-6-phenyl-2,3,8,8a-tetrahydroindolizin-5(1H)-one enantiomers

F. Scott Kimball
, Brandon J. Turunen
, Keith C. Ellis
, Richard H. Himes
, Gunda I. Georg

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

An enantiospecific synthesis was developed to generate both enantiomers of 7-(4-methoxyphenyl)-6-phenyl-2,3,8,8a-tetrahydroindolizin-5(1H)-one. A biological assay utilizing the HCT-116 colon cancer cell line to determine the cytotoxicity of these analogs revealed that only the (R)-enantiomer exhibited appreciable cytotoxicity with an IC₅₀ value of 0.2 μM.

Original language	English (US)
Pages (from-to)	4367-4377
Number of pages	11
Journal	Bioorganic and Medicinal Chemistry
Volume	16
Issue number	8
DOIs	https://doi.org/10.1016/j.bmc.2008.02.073
State	Published - Apr 15 2008

Bibliographical note

Funding Information:
These studies were supported by the National Cancer Institute (CA 90602 and N01-CM-67259). B.J.T. was supported by the Department of Defense Breast Cancer Predoctoral Fellowship (DAMD17-02-1-0435). We thank Deborah A. Bohlander for conducting the cytotoxicity assays and Dr. Dinah Dutta for the synthesis of (±)-tylophorine ( Table 1 ). 10

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Colon cancer
Enantiospecific synthesis
HCT-116
Tetrahydroindolizinones

Publisher link

10.1016/j.bmc.2008.02.073

Find It

Find It at U of M Libraries

Cite this

@article{591c08eb54134527a4c1b804bf05b17f,

title = "Enantiospecific synthesis and cytotoxicity of 7-(4-methoxyphenyl)-6-phenyl-2,3,8,8a-tetrahydroindolizin-5(1H)-one enantiomers",

abstract = "An enantiospecific synthesis was developed to generate both enantiomers of 7-(4-methoxyphenyl)-6-phenyl-2,3,8,8a-tetrahydroindolizin-5(1H)-one. A biological assay utilizing the HCT-116 colon cancer cell line to determine the cytotoxicity of these analogs revealed that only the (R)-enantiomer exhibited appreciable cytotoxicity with an IC50 value of 0.2 μM.",

keywords = "Colon cancer, Enantiospecific synthesis, HCT-116, Tetrahydroindolizinones",

author = "Kimball, \{F. Scott\} and Turunen, \{Brandon J.\} and Ellis, \{Keith C.\} and Himes, \{Richard H.\} and Georg, \{Gunda I.\}",

note = "Funding Information: These studies were supported by the National Cancer Institute (CA 90602 and N01-CM-67259). B.J.T. was supported by the Department of Defense Breast Cancer Predoctoral Fellowship (DAMD17-02-1-0435). We thank Deborah A. Bohlander for conducting the cytotoxicity assays and Dr. Dinah Dutta for the synthesis of (±)-tylophorine ( Table 1 ). 10 ",

year = "2008",

month = apr,

day = "15",

doi = "10.1016/j.bmc.2008.02.073",

language = "English (US)",

volume = "16",

pages = "4367--4377",

journal = "Bioorganic and Medicinal Chemistry",

issn = "0968-0896",

publisher = "Elsevier Ltd",

number = "8",

}

TY - JOUR

T1 - Enantiospecific synthesis and cytotoxicity of 7-(4-methoxyphenyl)-6-phenyl-2,3,8,8a-tetrahydroindolizin-5(1H)-one enantiomers

AU - Kimball, F. Scott

AU - Turunen, Brandon J.

AU - Ellis, Keith C.

AU - Himes, Richard H.

AU - Georg, Gunda I.

N1 - Funding Information: These studies were supported by the National Cancer Institute (CA 90602 and N01-CM-67259). B.J.T. was supported by the Department of Defense Breast Cancer Predoctoral Fellowship (DAMD17-02-1-0435). We thank Deborah A. Bohlander for conducting the cytotoxicity assays and Dr. Dinah Dutta for the synthesis of (±)-tylophorine ( Table 1 ). 10

PY - 2008/4/15

Y1 - 2008/4/15

N2 - An enantiospecific synthesis was developed to generate both enantiomers of 7-(4-methoxyphenyl)-6-phenyl-2,3,8,8a-tetrahydroindolizin-5(1H)-one. A biological assay utilizing the HCT-116 colon cancer cell line to determine the cytotoxicity of these analogs revealed that only the (R)-enantiomer exhibited appreciable cytotoxicity with an IC50 value of 0.2 μM.

AB - An enantiospecific synthesis was developed to generate both enantiomers of 7-(4-methoxyphenyl)-6-phenyl-2,3,8,8a-tetrahydroindolizin-5(1H)-one. A biological assay utilizing the HCT-116 colon cancer cell line to determine the cytotoxicity of these analogs revealed that only the (R)-enantiomer exhibited appreciable cytotoxicity with an IC50 value of 0.2 μM.

KW - Colon cancer

KW - Enantiospecific synthesis

KW - HCT-116

KW - Tetrahydroindolizinones

UR - https://www.scopus.com/pages/publications/42149167560

UR - https://www.scopus.com/pages/publications/42149167560#tab=citedBy

U2 - 10.1016/j.bmc.2008.02.073

DO - 10.1016/j.bmc.2008.02.073

M3 - Article

C2 - 18343127

AN - SCOPUS:42149167560

SN - 0968-0896

VL - 16

SP - 4367

EP - 4377

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

IS - 8

ER -

Enantiospecific synthesis and cytotoxicity of 7-(4-methoxyphenyl)-6-phenyl-2,3,8,8a-tetrahydroindolizin-5(1H)-one enantiomers

Abstract

Bibliographical note

UN SDGs

Keywords

Publisher link

Find It

Other files and links

Fingerprint

Cite this